The Effect of White and Pink Noise on Hospitalized Older Adults
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to determine if using an over-the-counter, commercially available sleep noise machine playing pink or white noise will reduce the incidence of delirium in hospitalized patients over the age of 65. Delirium is an acute change in cognition which commonly occurs in hospitalized older adults, and is linked with sleep-wake cycle disturbance. Delirium is associated with increased morbidity and mortality as well as longer hospital stays. This project will record delirium screening scores for those receiving the intervention and comparing them to baseline data. Reducing delirium rates using a noninvasive, inexpensive method in a hospital setting could have a significant impact on patient outcomes and potentially reduce costs associated with longer hospital stays. It is anticipated that white/pink noise played at night will decrease rates of delirium in hospitalized older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2018
CompletedFirst Posted
Study publicly available on registry
April 2, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2018
CompletedJanuary 10, 2019
January 1, 2019
2 months
March 26, 2018
January 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nursing Delirium Screening Scale (Nu-DESC) Score
Nursing Delirium Screening Scale (Nu-DESC) scores, which are already routinely charted by staff nurses, will be collected after the PI sets up the white/pink noise intervention. A score of \>2 is indicative of delirium.
Collected every 12-hours shift and as needed for acute change in mental status from baseline through discharge for a minimum of 3 nights not to exceed 14 days.
Study Arms (2)
Intervention Group
EXPERIMENTALThe PI will set up the PicTek white/pink noise machine on the bedside table, and it will automatically turn on at 2200 and off at 0700 to the patient's preferred sound. The staff nurses will chart Nu-DESC scores every shift and as needed for change in mental status as is the current policy. The PI will collect Nu-DESC scores for the duration of the participants' hospital stays, age, race, gender, presence of a dementia diagnosis, and use of a pharmacological sleep aid.
Control Group
OTHERThe PI will perform a chart review of patients who were admitted the month prior to the intervention being implemented. The PI will collect Nu-DESC scores for the duration of the participants' hospital stays, age, race, gender, presence of a dementia diagnosis, and use of a pharmacological sleep aid. These patients will receive the standard of care for delirium prevention.
Interventions
White and/or pink noise will be played from 2200 to 0700 using the PicTek® white noise machine.
Standard of care including lights on during the day and off at night, getting the patient out of bed for meals, presence of a large wall clock in the room, updating the whiteboard with current day, consistent reorientation of patient, geriatrician consults as needed, and pain management.
Eligibility Criteria
You may qualify if:
- English-speaking
- years of age or older
- have an estimated hospital stay of 3 or more nights
- have no known hearing deficits or wear hearing aids
- be free of delirium on admission
- be legally able to consent
You may not qualify if:
- non-English-speaking
- less than 65 years of age
- have known hearing deficits or wear hearing aids
- have delirium on admission
- cannot legally consent to participation
- transferred to/from the ICU before/during being enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UAB Highlands Hospital
Birmingham, Alabama, 35205, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Latricia D Weed, PhD
Troy University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary Investigator
Study Record Dates
First Submitted
March 26, 2018
First Posted
April 2, 2018
Study Start
October 1, 2018
Primary Completion
December 8, 2018
Study Completion
December 8, 2018
Last Updated
January 10, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available at this time since this is a small study. The protocol can be made available to other researchers at their request without the inclusion of IPD ensuring participant privacy.